V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10364838 | 10040090 | 1.61 | 71.25 | Palliative (P) | 2016-04-25 | 2016-05-02 | CHOP R - 21 days | 02 | N | CHOP R | 101614114 |
| 10364923 | 10040091 | null | 47.3 | null | 2021-03-18 | 2021-03-20 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100868919 |
| 10364994 | 10040092 | 1.65 | null | Palliative (P) | 2017-11-09 | 2017-12-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100866053 |
| 10365389 | 10040094 | 1.52 | 50 | null | 2019-12-28 | 2019-12-28 | Irinotecan + Modified De Gramont | N | N | FLUOROURACIL + IRINOTECAN | 101750908 |
| 10365446 | 10040095 | 1.78 | 85.15 | null | 2021-04-28 | 2021-04-28 | Irinotecan + Modified De Gramont | N | null | FLUOROURACIL + IRINOTECAN | 100684787 |
| 10365670 | 10040098 | null | 81.8 | Neo-adjuvant (N) | 2021-08-20 | 2021-08-20 | Cisplatin + Vinorelbine (PO) | 02 | null | BCG | 101222193 |
| 10365708 | 10040099 | 1.76 | 58 | Disease modification (D) | 2020-04-26 | 2020-04-26 | Acalabrutinib | Y | N | ACALABRUTINIB | 100649131 |
| 10365874 | 10040100 | 1.82 | null | Curative (C) | 2020-03-05 | 2020-03-07 | Gemcitabine + Capecitabine | 02 | Y | TRIAL | 101308898 |
| 10365901 | 10040101 | 1.62 | 81.2 | Palliative (P) | 2019-07-24 | 2019-07-26 | DARATUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100204129 |
| 10365940 | 10040102 | 1.81 | 65 | null | 2016-04-05 | 2016-04-06 | FEC 100 + DOCETAXEL | 02 | null | DABRAFENIB + TRAMETINIB | 101386629 |
| 10365977 | 10040103 | 1.8 | 98.6 | Neo-adjuvant (N) | 2022-01-14 | 2022-01-14 | POMALIDOMIDE | 02 | N | CAPECITABINE + GEMCITABINE | 101150206 |
| 10366156 | 10040104 | 1.59 | 70.9 | Adjuvant (A) | null | 2019-06-28 | CHOP R - 21 days | 02 | N | CHOP R | 100278224 |
| 10367063 | 10040106 | null | 0 | null | 2018-05-29 | 2018-06-19 | Trial Unspecified | 02 | null | PAZOPANIB | 100261662 |
| 10367181 | 10040107 | null | 70.25 | null | 2019-08-21 | 2019-09-07 | FLUOROURACIL | 02 | Y | FLUOROURACIL | 101782282 |
| 10367195 | 10040108 | 1.62 | 60.6 | null | 2019-03-10 | 2019-03-21 | FLUOROURACIL | 02 | null | FLUOROURACIL | 101844093 |
| 10367416 | 10040110 | 1.71 | 73.4 | Curative (C) | 2018-06-05 | 2018-06-21 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100161356 |
| 10367688 | 10040114 | 1.82 | 84.6 | Adjuvant (A) | 2019-07-18 | 2020-02-24 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101471657 |
| 10367822 | 10040116 | 1.67 | 89.9 | 03 | 2018-07-18 | 2018-07-23 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101834355 |
| 10367828 | 10040117 | 1.65 | 55 | Adjuvant (A) | 2019-11-21 | 2019-12-03 | Carboplatin + Pembrolizumab + Pemetrexed | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101414832 |
| 10367882 | 10040119 | 1.73 | null | null | 2019-11-15 | 2019-11-19 | R Chlorambucil | 02 | Y | CHLORAMBUCIL + RITUXIMAB | 100594389 |
| 10368044 | 10040120 | 1.67 | 90.4 | Curative (C) | 2019-08-14 | 2019-08-18 | POMALIDOMIDE | 02 | N | CYTARABINE | 100186007 |
| 10368054 | 10040121 | 1.62 | 84.8 | null | 2016-02-12 | 2016-02-12 | Gemcitabine + Capecitabine | 02 | null | MITOMYCIN | 100298284 |
| 10368103 | 10040122 | 1.7 | 72.15 | Palliative (P) | 2020-04-23 | 2020-05-04 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 100875923 |
| 10368209 | 10040126 | 1.7 | 89.4 | Palliative (P) | 2020-01-16 | 2020-01-23 | BCG Intravesical | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101721734 |
| 10368225 | 10040127 | 1.6 | 75 | Adjuvant (A) | 2019-05-11 | 2019-05-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100162808 |
| 10368266 | 10040128 | 1.65 | null | Palliative (P) | null | 2020-04-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101606714 |
| 10368278 | 10040129 | 1.73 | null | Palliative (P) | 2020-04-01 | 2020-05-06 | Sunitinib | 02 | N | TRIAL | 100223058 |
| 10368315 | 10040131 | 1.56 | 86.4 | 03 | null | null | CHOP R | N | N | CHOP R | 100683518 |
| 10368418 | 10040133 | 1.76 | 75.4 | Palliative (P) | null | 2019-06-07 | CTD Attenuated (Thalidomide 100mg) | null | N | CAPECITABINE + CISPLATIN | 100196859 |
| 10368440 | 10040134 | 1.79 | 54.6 | Neo-adjuvant (N) | 2017-11-21 | 2017-11-21 | Cytarabine Low Dose | N | N | CLADRIBINE | 101135876 |
| 10368459 | 10040136 | 1.65 | 72.4 | Adjuvant (A) | 2020-08-21 | 2020-08-22 | FEC 60 or 75 | Y | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101222191 |
| 10368556 | 10040137 | 1.64 | 82.2 | Curative (C) | 2019-10-14 | 2019-10-31 | Cytarabine Low Dose | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100653178 |
| 10368655 | 10040139 | 1.56 | 72 | Adjuvant (A) | 2019-12-01 | 2020-01-01 | DARATUMUMAB | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100485120 |
| 10368732 | 10040140 | 1.64 | 71.2 | Palliative (P) | 2017-09-07 | 2017-09-13 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 101662816 |
| 10368762 | 10040142 | 1.6 | 58.5 | 03 | 2021-06-25 | 2021-07-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100930245 |
| 10368801 | 10040143 | 1.86 | 66.2 | Palliative (P) | 2019-04-10 | 2019-04-16 | Trial Unspecified | 02 | null | CISPLATIN + FLUOROURACIL | 101799038 |
| 10368830 | 10040144 | 1.7 | 88 | Curative (C) | 2016-10-02 | 2016-10-16 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100754278 |
| 10368858 | 10040146 | 1.81 | 62 | 03 | 2019-05-05 | 2019-05-11 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101322649 |
| 10368865 | 10040147 | 1.78 | 59.9 | null | 2019-05-30 | 2019-06-25 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 101799902 |
| 10369028 | 10040151 | 1.81 | 101 | Palliative (P) | 2017-10-27 | 2017-10-29 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100358720 |
| 10369039 | 10040153 | 1.75 | 82.6 | 03 | 2018-09-02 | 2018-09-16 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101055997 |
| 10369060 | 10040154 | 1.55 | 67.4 | 03 | 2020-05-13 | 2020-05-25 | DABRAFENIB + TRAMETINIB | N | null | VENETOCLAX | 101710990 |
| 10369071 | 10040155 | 1.64 | 0 | Palliative (P) | null | 2019-12-10 | CHOP - 21 days | 02 | null | CAPECITABINE + CISPLATIN | 100324508 |
| 10369148 | 10040157 | 1.83 | 69.7 | 03 | 2016-05-27 | 2016-06-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101793509 |
| 10369153 | 10040158 | null | 82.3 | 03 | 2018-03-16 | 2018-03-19 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100332133 |
| 10369157 | 10040159 | 1.53 | 73.6 | Palliative (P) | 2019-06-21 | 2019-07-17 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100429026 |
| 10369175 | 10040160 | null | null | Palliative (P) | 2017-05-05 | 2017-05-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101218922 |
| 10369193 | 10040161 | null | 0 | null | 2019-08-14 | 2019-08-16 | Gemcitabine + Capecitabine | 02 | null | DARATUMUMAB | 101545834 |
| 10369300 | 10040162 | 0 | 0 | Palliative (P) | 2020-02-24 | 2020-02-24 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100571173 |
| 10369529 | 10040165 | 1.6 | 63 | Palliative (P) | 2019-06-13 | 2019-06-18 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101215284 |